Kaiser Group Health is a clinical research site located in Portland, Oregon, United States 97227.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Kaiser Group Health has participated in 2 clinical trials.
Therapeutic areas: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Non Small Cell Lung Cancer.
Sponsors: Millennium Pharmaceuticals, Inc., Agennix.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Kaiser Group Health has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kaiser Group Health has 2 clinical trials on record. Their work covers Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Non Small Cell Lung Cancer.
Kaiser Group Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.